Cover Image
市场调查报告书

醣生物学的全球市场 ~2021年:酵素:糖基转移酶,神经胺糖酸酶,醣苷酶,设备:HPLC,质谱仪,MALDI-TOF,套件、试剂

Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application, End User - Global Forecast to 2021

出版商 MarketsandMarkets 商品编码 315373
出版日期 内容信息 英文 160 Pages
订单完成后即时交付
价格
Back to Top
醣生物学的全球市场 ~2021年:酵素:糖基转移酶,神经胺糖酸酶,醣苷酶,设备:HPLC,质谱仪,MALDI-TOF,套件、试剂 Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application, End User - Global Forecast to 2021
出版日期: 2017年01月30日 内容信息: 英文 160 Pages
简介

全球醣生物学市场2016年达到6亿4,950万美元,预计2016~2021年以年复合成长率13.3%发展,2021年达到12亿1,140万美元。政府及民营企业增加了蛋白质体学和糖组学的研究资金,制药公司和生物科技企业急速扩大了研究开发费,是大幅支撑该市场的成长的二大要素。另一方面,企业相继合并抑制市场的新加入,从而妨碍成长。

本报告提供全球醣生物学市场相关调查,各用途,各终端用户,各产品,及各地区的趋势,加入此市场的主要企业的市场占有率和简介等汇整数据。

第1章 简介

第2章 调查方法

第3章 摘要整理

第4章 高级见解

  • 醣生物学市场概要
  • 地理分析:各产品醣生物学市场
  • 各地区生命周期分析

第5章 市场概要

  • 简介
  • 市场动态
    • 促进要素
    • 阻碍要素
    • 机会
    • 课题

第6章 各产品市场

  • 简介
  • 酵素
    • 醣苷酶
    • 糖基转移酶
    • 神经胺糖酸酶
    • 唾液酸转移酶
    • 其他
  • 设备
    • 抗体阵列
    • HPLC
    • 凝集素阵列
    • MALDI-TOF
    • 质谱仪
    • 其他
  • 套件
    • 聚醣标记套件
    • 聚醣纯化套件
    • 聚醣释放套件
    • 其他
  • 试剂
    • 糖蛋白质
    • 单糖
    • 寡糖
    • 其他

第7章 各用途市场

  • 简介
  • 诊断
  • 药物研发、药物开发
  • 肿瘤学
  • 免疫学
  • 其他

第8章 各终端用户市场

  • 简介
  • 学术研究机关
  • 制药公司、生物科技企业
  • CRO(临床研究委外机构)

第9章 各地区市场

  • 简介
  • 北美
  • 欧洲
  • 亚洲
  • 其他

第10章 竞争环境

  • 市场占有率分析
    • 醣生物学酵素,套件,试剂市场
    • 醣生物学设备市场
  • 竞争趋势
    • 新产品上市
    • 扩大
    • 协定
    • 收购,合作,认证,其他

第11章 企业简介

  • 简介
  • Merck KGaA
  • TaKaRa BIO
  • 岛津制作所
  • Bruker Corporation
  • Waters Corporation
  • New England Biolabs Inc.
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • ProZyme, Inc.
  • Thermo Fisher Scientific, Inc.

第12章 附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: BT 2776

The global glycomics/glycobiology market is poised to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%. The glycomics/glycobiology market is segmented on the basis of product, application, end user, and region.

Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of the global glycomics/glycobiology market.

On the basis of product, the market is segmented into enzymes, instruments, kits, and reagents. The enzymes segment is projected to grow at the highest CAGR during the forecast period. This growth is mainly attributed to their consumable nature and wide applications in a variety of R&D and drug discovery procedures. The enzymes segment is further divided into glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, and other enzymes.

On the basis of application, the market is segmented into diagnostics, drug discovery & development, oncology, immunology, and other applications. In 2016, the drug discovery and development segment is expected to account for the largest share of the market. This growth can be attributed to increase in R&D activities for the development of novel drugs and therapies.

On the basis of region, the market is segmented into North America, Asia, Europe, and RoW. The Asian market is estimated to grow at the highest CAGR during the forecast period. This growth is mainly attributed to the increasing commercialization of R&D by pharmaceutical and biotechnology companies, growing demand for personalized medicine, and rising importance of companion diagnostics.

Apart from comprehensive regional and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on the key players in the glycomics/glycobiology market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, regional focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms garner a higher market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios of the top players in the glycomics/glycobiology market. The report analyzes the glycomics/glycobiology by product, application, end user, and region
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the glycomics/glycobiology market
  • Competitive Assessment: In-depth assessment of the market strategies, regional and business segments, and product portfolios of the leading players in the glycomics/glycobiology market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various glycomics/glycobiology offerings across regions
  • Market Diversification: Exhaustive information about new products and services, untapped regions, recent developments, and investments in the glycomics/glycobiology market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKETS DEFINITION
  • 1.3. MARKETS COVERED
    • 1.3.1. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. MARKET SCOPE
  • 1.6. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GLYCOMICS: MARKET OVERVIEW (2016-2021)
  • 4.2. GEOGRAPHIC ANALYSIS: GLYCOMICS MARKET, BY PRODUCT
  • 4.3. LIFE CYCLE ANALYSIS, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increase in Funding for Proteomics and Glycomics Research, Growing R&D Expenditure
      • 5.2.1.1. Growth of the Proteomics Market
      • 5.2.1.2. Technological Advancements in Glycomics Instrumentation
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High Degree of Consolidation Hinders Entry of New Players to the Market
      • 5.2.2.2. Stringent Regulatory Frameworks and Time-consuming Approval Processes
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Increased Use of Personalized Medicine
      • 5.2.3.2. Biomarker Identification
      • 5.2.3.3. Developing Countries and Emerging Markets
    • 5.2.4. CHALLENGES
      • 5.2.4.1. High Costs of Tools & Instruments and Their Maintenance

6. GLYCOMICS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. ENZYMES
    • 6.2.1. GLYCOSIDASES
    • 6.2.2. GLYCOSYLTRANSFERASES
    • 6.2.3. NEURAMINIDASES
    • 6.2.4. SIALYLTRANSFERASES
    • 6.2.5. OTHER GLYCOMICS ENZYMES
  • 6.3. INSTRUMENTS
    • 6.3.1. ANTIBODY ARRAYS
    • 6.3.2. HPLC
    • 6.3.3. LECTIN ARRAYS
    • 6.3.4. MALDI-TOF
    • 6.3.5. MASS SPECTROMETERS
    • 6.3.6. OTHER GLYCOMICS INSTRUMENTS
  • 6.4. KITS
    • 6.4.1. GLYCAN LABELING KITS
    • 6.4.2. GLYCAN PURIFICATION KITS
    • 6.4.3. GLYCAN RELEASE KITS
    • 6.4.4. OTHER GLYCOMICS KITS
  • 6.5. REAGENTS
    • 6.5.1. GLYCOPROTEINS
    • 6.5.2. MONOSACCHARIDES
    • 6.5.3. OLIGOSACCHARIDES
    • 6.5.4. OTHER REAGENTS

7. GLYCOMICS MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. DIAGNOSTICS
  • 7.3. DRUG DISCOVERY & DEVELOPMENT
  • 7.4. ONCOLOGY
  • 7.5. IMMUNOLOGY
  • 7.6. OTHER APPLICATIONS

8. GLYCOMICS MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. ACADEMIC RESEARCH INSTITUTES
  • 8.3. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 8.4. CONTRACT RESEARCH ORGANIZATIONS

9. GLYCOMICS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. FRANCE
    • 9.3.3. U.K.
    • 9.3.4. ITALY
    • 9.3.5. SPAIN
    • 9.3.6. ROE
  • 9.4. ASIA
    • 9.4.1. CHINA
    • 9.4.2. JAPAN
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA
  • 9.5. REST OF THE WORLD (ROW)
    • 9.5.1. SOUTH AMERICA
    • 9.5.2. MIDDLE EAST AND AFRICA
    • 9.5.3. PACIFIC AND OCEANIA

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
    • 10.2.1. GLYCOMICS ENZYMES, KITS, AND REGENTS
    • 10.2.2. GLYCOMICS INSTRUMENTS
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. PRODUCT LAUNCHES
    • 10.3.2. EXPANSIONS
    • 10.3.3. AGREEMENTS
    • 10.3.4. ACQUISITIONS, COLLABORATIONS, APPROVALS, AND OTHERS

11. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 11.1. INTRODUCTION
  • 11.2. MERCK KGAA
  • 11.3. TAKARA BIO, INC.
  • 11.4. SHIMADZU CORPORATION
  • 11.5. BRUKER CORPORATION
  • 11.6. WATERS CORPORATION
  • 11.7. NEW ENGLAND BIOLABS INC.
  • 11.8. AGILENT TECHNOLOGIES, INC.
  • 11.9. DANAHER CORPORATION
  • 11.10. PROZYME, INC.
  • 11.11. THERMO FISHER SCIENTIFIC, INC.

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLYCOMICS MARKET SUMMARY
  • TABLE 2: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 3: GLYCOMICS ENZYMES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 4: GLYCOMICS ENZYMES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 5: GLYCOSIDASES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 6: GLYCOSYLTRANSFERASES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: NEURAMINIDASES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: SIALYLTRANSFERASES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: OTHER GLYCOMICS ENZYMES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: GLYCOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 11: GLYCOMICS INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: ANTIBODY ARRAYS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: HPLC MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: LECTIN ARRAYS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: MALDI-TOF MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: MASS SPECTROMETRY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: OTHER GLYCOMICS INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: GLYCOMICS KITS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 19: GLYCOMICS KITS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: GLYCAN LABELING KITS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: GLYCAN PURIFICATION KITS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: GLYCAN RELEASE KITS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: OTHER GLYCOMICS KITS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: GLYCOMICS REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 25: GLYCOMICS REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: GLYCOPROTEINS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: MONOSACCHARIDES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: OLIGOSACCHARIDES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: OTHER REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: GLYCOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 31: GLYCOMICS MARKET SIZE FOR DIAGNOSTICS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: GLYCOMICS MARKET SIZE FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: GLYCOMICS MARKET SIZE FOR ONCOLOGY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: GLYCOMICS MARKET SIZE FOR IMMUNOLOGY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: GLYCOMICS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: GLYCOMICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 37: GLYCOMICS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 38: GLYCOMICS MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: GLYCOMICS MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: GLYCOMICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 41: NORTH AMERICA: GLYCOMICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: NORTH AMERICA: GLYCOMICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 43: NORTH AMERICA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 44: NORTH AMERICA: GLYCOMICS ENZYMES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 45: NORTH AMERICA: GLYCOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 46: NORTH AMERICA: GLYCOMICS KITS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 47: NORTH AMERICA: GLYCOMICS REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 48: NORTH AMERICA: GLYCOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 49: U.S.: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 50: CANADA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 51: EUROPE: GLYCOMICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 52: EUROPE: GLYCOMICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 53: EUROPE: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 54: EUROPE: GLYCOMICS ENZYMES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 55: EUROPE: GLYCOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 56: EUROPE: GLYCOMICS KITS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 57: EUROPE: GLYCOMICS REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 58: EUROPE: GLYCOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 59: GERMANY: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 60: FRANCE: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 61: U.K.: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 62: ITALY: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 63: SPAIN: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 64: ROE: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 65: ASIA: GLYCOMICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 66: ASIA: GLYCOMICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 67: ASIA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 68: ASIA: GLYCOMICS ENZYMES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 69: ASIA: GLYCOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 70: ASIA: GLYCOMICS KITS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 71: ASIA: GLYCOMICS REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 72: ASIA: GLYCOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 73: CHINA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 74: JAPAN: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 75: INDIA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 76: ROA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 77: ROW: GLYCOMICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 78: ROW: GLYCOMICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 79: ROW: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 80: ROW: GLYCOMICS ENZYMES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 81: ROW: GLYCOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 82: ROW: GLYCOMICS KITS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 83: ROW: GLYCOMICS REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 84: ROW: GLYCOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 85: SOUTH AMERICA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 86: MIDDLE EAST AND AFRICA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 87: PACIFIC AND OCEANIA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 88: PRODUCT LAUNCHES, 2013-2016
  • TABLE 89: EXPANSIONS, 2013-2016
  • TABLE 90: AGREEMENTS, 2013-2016
  • TABLE 91: ACQUISITIONS, COLLABORATIONS, APPROVALS, AND OTHERS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL GLYCOMICS MARKET
  • FIGURE 2: RESEARCH METHODOLOGY
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, & REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: ENZYMES TO REGISTER THE HIGHEST CAGR BETWEEN 2016 & 2021
  • FIGURE 8: GLYCOSIDASES TO DOMINATE THE GLYCOMICS ENZYMES MARKET IN 2016
  • FIGURE 9: MASS SPECTROMETRY TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 10: GLYCAN RELEASE KITS TO DOMINATE THE GLYCOMICS KITS MARKET IN 2016
  • FIGURE 11: OLIGOSACCHARIDES TO COMMAND THE LARGEST SHARE OF THE GLYCOMICS REAGENTS MARKET IN 2016
  • FIGURE 12: INCREASING FUNDING IN GLYCOMICS AND PROTEOMICS RESEARCH TO DRIVE THE NORTH AMERICAN GLYCOMICS MARKET
  • FIGURE 13: INCREASING FUNDING FOR PROTEOMICS & GLYCOMICS RESEARCH IS AN IMPORTANT GROWTH DRIVER FOR THE GLYCOMICS MARKET
  • FIGURE 14: ENZYMES TO ACCOUNT FOR THE LARGEST PRODUCT SEGMENT OF THE GLYCOMICS MARKET IN 2016
  • FIGURE 15: ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 16: ASIA HOLDS LUCRATIVE GROWTH OPPORTUNITIES FOR GLYCOMICS PRODUCTS DURING THE FORECAST PERIOD
  • FIGURE 17: INCREASING GOVERNMENT AND PRIVATE FUNDING FOR PROTEOMICS AND GLYCOMICS RESEARCH TO DRIVE THE DEMAND FOR GLYCOMICS PRODUCTS
  • FIGURE 18: GLYCOMICS MARKET IN ASIA TO REGISTER HIGHEST GROWTH DURING THE FORECAST
  • FIGURE 19: NORTH AMERICA: GLYCOMICS MARKET SNAPSHOT
  • FIGURE 20: ASIA: GLYCOMICS MARKET SNAPSHOT
  • FIGURE 21: KEY DEVELOPMENTS IN THE GLOBAL GLYCOMICS MARKET, 2013-2016
  • FIGURE 22: GLOBAL GLYCOMICS ENZYMES, KITS, AND REAGENTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 23: BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES IS THE KEY STRATEGY ADOPTED BY PLAYERS IN THE GLYCOMICS MARKET BETWEEN 2013 & 2016
  • FIGURE 24: GEOGRAPHIC REVENUE MIX OF TOP 5 MARKET PLAYERS
  • FIGURE 25: MERCK KGAA: COMPANY SNAPSHOT (2015)
  • FIGURE 26: TAKARA BIO, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 27: SHIMADZU CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 28: BRUKER CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 29: WATERS CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 30: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 31: DANAHER CORPORATION COMPANY SNAPSHOT (2015)
  • FIGURE 32: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2015)
Back to Top